Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    The Janus Corner

    The Janus Corner

    wadmin1By wadmin1January 1, 2019Updated:August 10, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I.E.Cock1,2

    1School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

    2Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

    Pharmacognosy Communications,2019,9,1,34-35.
    DOI:10.5530/pc.2019.1.7.
    Published: January 2019
    Type: The Janus Corner

    ABSTRACT

    Scutellaria baicalensis (commonly known as Huang-Qin) is a plant used in traditional Chinese medicine (TCM) to treat fever, as well as liver and lung disorders. A recent study isolated the flavones wogonin and baicalin from the roots of this species and tested them for antioxidant capacity and antiviral activity.1 Interestingly, whilst these effects were noted, the authors also noted that wogonin and baicalin induced cell death in human cancer cells yet were nontoxic to normal human cell lines. Furthermore, wogonin and baicalin stopped tumour growth in an in vivo model system, indicating there efficacy and potential in cancer chemotherapy. Whilst many flavones have previously been linked with useful therapeutic properties the S. baicalensis root flavones wogonin and baicalin are unique in that they lack a hydroxyl group in their structure. Flavones are generally synthesised from naringenin, which contains the hydroxyl group. No known enzyme that removes the hydroxyl group has been found in S. baicalensis roots, making its mechanism of synthesis unique. The authors of the study determined that wogonin and baicalin were instead synthesised from a different precursor, chrysin (Figure 1). Understanding this pathway may enable the production of these bioactive flavones in large quantities. Read More ….

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up